At night, it showed a trend to increase wakefulness, decreased transitions from W to N, and increased the average duration of wakefulness, thereby maintaining a stable sleep-wake structure (Fig. 7E–G ).
← all excerpts
Butyrate improves abnormal sleep architecture in a Parkinson's disease mouse model via BDNF/TrkB signaling.
1
—
—